Katherine Bailey

BSc, MD

Investigator and Pediatric Anesthesiologist, BC Children's Hospital
Pediatric Anesthesia Fellowship Director

My research interests are how to improve outcomes for infants and children undergoing anesthesia for many different types of surgery, and specifically for infants and children requiring brain surgery. I am also interested in advanced techniques for breathing support in infants undergoing anesthesia for surgical procedures. In addition to directly improving the quality of patient care, I am also interested in how to improve the quality of education for specialist doctors learning how to provide anesthesia for infants and children.

Academic Affiliations

  • Clinical Associate Professor, , Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia
  • Research Theme: Evidence to Innovation
  • Research Group(s): Clinical Practice, Outcomes and Innovation

Contact Information

Location

4480 Oak Street, Vancouver, British Columbia, Canada, V6H 3V4

Timing Is Everything

Paediatric Anaesthesia

Chen, J.C.-H. and Bailey, K.M. and Buswell, V.

DOI: 10.1111/pan.70036

Pediatric anesthesia in North America

Paediatric Anaesthesia

Srinivasan, I. and Whyte, S. and Bailey, K. and Antrobus, T. and Hinkson-LaCorbinire, K. and Martin, T.W. and Cravero, J.P. and Mason, L.

DOI: 10.1111/pan.14872

Anesthesia and neurodevelopment after 20 years: where are we now and where to next?,Anesthsie et neurodveloppement, 20 ans aprs: regard actuel et perspectives davenir

Canadian Journal of Anesthesia

Bailey, K.M. and Whyte, S.D.

DOI: 10.1007/s12630-022-02352-8

Competency-Based Medical Education: Are Canadian Pediatric Anesthesiologists Ready?

Cureus

Katherine Bailey and Nicholas C West and Clyde Matava

DOI: 10.7759/cureus.22344

02 / 2022

Safety of antifibrinolytics in 6583 pediatric patients having craniosynostosis surgery: A decade of data reported from the multicenter Pediatric Craniofacial Collaborative Group

Paediatric Anaesthesia

King, M.R. and Staffa, S.J. and Stricker, P.A. and Prez-Pradilla, C. and Nelson, O. and Benzon, H.A. and Goobie, S.M. and Abruzzese, C. and Asmal, I. and Bailey, K. and Barker, N. and Bhandari, A. and Beethe, A. and Binstock, W. and van den Bosch, C. and Bradford, V. and Bradley, J. and Bryan, K. and Brzenski, A. and Budac, S. and Busso, V. and de Castro, A. and Castro-Frenzel, K. and Chhabada, S. and Chiao, F. and Ching, J. and Cladis, F. and Claypool, D. and Collins, M. and Correll, L. and Costandi, A. and Dabek, R. and Dalesio, N. and Downard, M. and Echeverry, P. and Edala, T. and Edwards, C. and Ellison, P.R. and Enicker, B. and Falcon, R. and Fernandez, A. and Fernandez, P. and Fiadjoe, J. and Franzen, M. and Gangadharan, M. and Glover, C. and Gosman, A. and Governale, L. and Grivoyannis, A. and Grap, S. and Gries, H. and Griffin, A. and Hajduk, J. and Haas, T. and Hansen, J. and Hetmaniuk, M. and Homi, H.M. and Hsieh, H. and Hsieh, V. and Huang, H. and Ingelmo, P. and Ivanova, I. and Jain, R. and Kamel, G. and Kanmanthreddy, S. and Kars, M. and Koller, J. and Kowalczyk-Derderian, C. and Kugler, J. and Labovsky, K. and Lakheeram, I. and Lazar, A. and Lee, A. and Lee, J. and Madaree, A. and Malviya, S. and Martinez, J.L. and Mason, A. and Medellin, E. and Mehta, V. and Meier, P.M. and Levy, H.M. and Mueller, M. and Muhly, W.T. and Muldowney, B. and Nause-Osthoff, R. and Nelson, J. and Nicholson, J. and Nguyen, K.-P. and Nguyen, T. and Owens-Stubblefield, M. and Pankratz, M. and Parekh, U.R. and Parikh, M. and Patel, J. and Patel, R. and Patel, V. and Petersen, T. and Post, J. and Poteet-Schwartz, K. and Puglia, M.P. and Reddy, S.K. and Reid, R. and Ricketts, K. and McCormick, M.R. and Ryan, L. and Sbrollini, K. and Seidman, P. and Seubert, C. and Salik, I. and Singh, D.J. and Singhal, N.R. and Skitt, R. and Soneru, C. and Sorial, E. and Starker, E. and Stubbeman, B. and Sunder, R. and Sung, W. and Syed, T. and Szmuk, P. and Taicher, B.M. and Taylor, J. and Taylor, K. and Thompson, D. and Titler, S.S. and Ungar-Kastner, G. and Whyte, S. and Wong, A. and Wong, K. and Yates, H. and Zamora, L.

DOI: 10.1111/pan.14540

Anesthetic management of a young adult with complex congenital heart disease and bronchopleural fistula for rigid bronchoscopy

Anesthesia and Analgesia

Bailey, K.M. and Gottlieb, E.A. and Edmonds Jr., J.L. and Miller-Hance, W.C.

DOI: 10.1213/01.ane.0000243331.61117.f2

The pediatric patient and upper respiratory infections

Best Practice & Research Clinical Anaesthesiology

T ELWOOD and K BAILEY

DOI: 10.1016/s1521-6896(04)00071-0

03 / 2005

Utilizing humidified high-flow nasal cannula (HHFNC) to prevent oxygen desaturation in premature neonates with retinopathy of prematurity (ROP) undergoing indirect diode laser photocoagulation therapy

Retinopathy of prematurity (ROP) is a vaso-proliferative disease affecting the developing retinal vessels of premature infants, potentially leading to retinal detachment and blindness. Known major risk factors for developing ROP are low gestational age, hyperoxia, and mechanical ventilation. The gold standard of ROP treatment is laser photocoagulation of the non-vascularized retina under anesthesia.

General anesthesia in premature infants is associated with significant risks, including apnea, arterial blood oxygen desaturation, potential exposure to high inspired oxygen concentrations, and risks related to tracheal intubation. Tracheal intubation to provide mechanical ventilation in neonates has been associated with rare but potentially severe undesired consequences.

HHFNC therapy opens the airway and alveoli through the generation of distending pressure, reduces nasopharyngeal dead space, reduces work of breathing, and heats and humidifies inspired gas, allowing for apneic oxygenation while preventing collapse of the distal airways. There is good evidence that the application of HHFNC in the neonatal population to provide non-invasive respiratory support to prevent hypoxemia is both safe and feasible in the NICU, during anesthesia induction and intraoperative period to facilitate ear, nose and throat (ENT) and general surgery. HHFNC enables the neonate to breathe spontaneously under total intravenous anesthesia (TIVA) and could reduce or eliminate the need for tracheal intubation, mechanical ventilation, and the iatrogenic administration of high oxygen concentrations. More recently, HHFNC has been shown to promote regression of high-risk pre-threshold ROP.

Anesthetic Outcomes During Epilepsy Surgery using Electrocorticography (ECoG)

About one-third of people with epilepsy will eventually develop intractable seizures which are refractory to medical management. Electrocorticography (ECoG), a form of neuromonitoring, is considered to be the gold standard for assessing neuronal activity in patients with epilepsy, and is widely used for presurgical planning and intraoperatively to guide surgical resection of the lesion and epileptogenic zone. Anesthetic agents can impact the accuracy of electrocorticography during surgery.

We are currently conducting a prospective audit of 25 sequential Epilepsy surgery cases using ECoG to describe our institutional experience. Specifically, we are looking at the anesthetic technique being used, the quality of the ECoG being captured, and the one year seizure outcomes after epilepsy surgery.

Erector Spinae Plane (ESP) block for pain control after pyeloplasty surgery

Pyeloplasty is a surgical procedure used to correct a condition called ureteropelvic junction (UPJ) obstruction. Ureteropelvic junction (UPJ) obstruction is a blockage at the point where part of the kidney attaches to one of the tubes to the bladder (ureters). This blocks the flow of urine out of the kidney. One out of every 1500 babies is born with UPJ obstruction. Pain after pyeloplasty surgery is most severe in the first 24-48 hours after surgery.

The erector spinae plane (ESP) block is a paraspinal fascial plane block done under ultrasound guidance to inject local anesthetic between the tip of the transverse process of the thoracic or lumbar vertebra and the anterior fascia of the erector spinae muscles. The block targets the dorsal and ventral rami of the thoracic and abdominal spinal nerves to provide analgesia for multiple types of surgical procedures including pyeloplasty. Potential benefits of ESP blocks are improved post-operative analgesia, a reduction in the amount of post-operative opiates required, and decreased post-op nausea and vomiting.

Our Research

At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.

EXPLORE OUR RESEARCH

Stay in the Know

Sign up for compelling stories about innovative science, the doctors and researchers who turn ideas into discoveries and treatments, and the kids and families whose lives are changed.

This field is for validation purposes and should be left unchanged.